Your browser doesn't support javascript.
loading
Evaluation of Poly(N-Ethyl Pyrrolidine Methacrylamide) (EPA) and Derivatives as Polymeric Vehicles for miRNA Delivery to Neural Cells.
Soto, Altea; Nieto-Díaz, Manuel; Martínez-Campos, Enrique; Noalles-Dols, Ana; Barreda-Manso, María Asunción; Reviriego, Felipe; Reinecke, Helmut; Reigada, David; Muñoz-Galdeano, Teresa; Novillo, Irene; Gallardo, Alberto; Rodríguez-Hernández, Juan; Eritja, Ramón; Aviñó, Anna; Elvira, Carlos; M Maza, Rodrigo.
Afiliación
  • Soto A; Molecular Neuroprotection Group, Hospital Nacional de Parapléjicos (SESCAM), 45071 Toledo, Spain.
  • Nieto-Díaz M; Molecular Neuroprotection Group, Hospital Nacional de Parapléjicos (SESCAM), 45071 Toledo, Spain.
  • Martínez-Campos E; Polymer Functionalization Group, Instituto de Ciencia y Tecnología de Polímeros-Consejo Superior de Investigaciones Científicas (ICTP-CSIC), Departamento de Química Macromolecular Aplicada, Juan de la Cierva 3, 28006 Madrid, Spain.
  • Noalles-Dols A; Group of Organic Synthesis and Bioevaluation, Associated Unit to the ICTP-IQM-CSIC, Instituto Pluridisciplinar, Universidad Complutense de Madrid, Paseo Juan XXIII, n◦ 1, 28040 Madrid, Spain.
  • Barreda-Manso MA; Molecular Neuroprotection Group, Hospital Nacional de Parapléjicos (SESCAM), 45071 Toledo, Spain.
  • Reviriego F; Functional Exploration and Neuromodulation of the Central Nervous System Group, Hospital Nacional de Parapléjicos (SESCAM), 45071 Toledo, Spain.
  • Reinecke H; Polymer Functionalization Group, Instituto de Ciencia y Tecnología de Polímeros-Consejo Superior de Investigaciones Científicas (ICTP-CSIC), Departamento de Química Macromolecular Aplicada, Juan de la Cierva 3, 28006 Madrid, Spain.
  • Reigada D; Polymer Functionalization Group, Instituto de Ciencia y Tecnología de Polímeros-Consejo Superior de Investigaciones Científicas (ICTP-CSIC), Departamento de Química Macromolecular Aplicada, Juan de la Cierva 3, 28006 Madrid, Spain.
  • Muñoz-Galdeano T; Molecular Neuroprotection Group, Hospital Nacional de Parapléjicos (SESCAM), 45071 Toledo, Spain.
  • Novillo I; Molecular Neuroprotection Group, Hospital Nacional de Parapléjicos (SESCAM), 45071 Toledo, Spain.
  • Gallardo A; Molecular Neuroprotection Group, Hospital Nacional de Parapléjicos (SESCAM), 45071 Toledo, Spain.
  • Rodríguez-Hernández J; Polymer Functionalization Group, Instituto de Ciencia y Tecnología de Polímeros-Consejo Superior de Investigaciones Científicas (ICTP-CSIC), Departamento de Química Macromolecular Aplicada, Juan de la Cierva 3, 28006 Madrid, Spain.
  • Eritja R; Polymer Functionalization Group, Instituto de Ciencia y Tecnología de Polímeros-Consejo Superior de Investigaciones Científicas (ICTP-CSIC), Departamento de Química Macromolecular Aplicada, Juan de la Cierva 3, 28006 Madrid, Spain.
  • Aviñó A; Department of Surfactants and Nanobiotechnology, Institute for Advanced Chemistry of Catalonia (IQAC), Spanish National Research Council (CSIC), Jordi Girona 18-26, 08034 Barcelona, Spain.
  • Elvira C; Networking Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), 08034 Barcelona, Spain.
  • M Maza R; Department of Surfactants and Nanobiotechnology, Institute for Advanced Chemistry of Catalonia (IQAC), Spanish National Research Council (CSIC), Jordi Girona 18-26, 08034 Barcelona, Spain.
Pharmaceutics ; 15(5)2023 May 10.
Article en En | MEDLINE | ID: mdl-37242702
MicroRNAs (miRNAs) are endogenous, short RNA oligonucleotides that regulate the expression of hundreds of proteins to control cells' function in physiological and pathological conditions. miRNA therapeutics are highly specific, reducing the toxicity associated with off-target effects, and require low doses to achieve therapeutic effects. Despite their potential, applying miRNA-based therapies is limited by difficulties in delivery due to their poor stability, fast clearance, poor efficiency, and off-target effects. To overcome these challenges, polymeric vehicles have attracted a lot of attention due to their ease of production with low costs, large payload, safety profiles, and minimal induction of the immune response. Poly(N-ethyl pyrrolidine methacrylamide) (EPA) copolymers have shown optimal DNA transfection efficiencies in fibroblasts. The present study aims to evaluate the potential of EPA polymers as miRNA carriers for neural cell lines and primary neuron cultures when they are copolymerized with different compounds. To achieve this aim, we synthesized and characterized different copolymers and evaluated their miRNA condensation ability, size, charge, cytotoxicity, cell binding and internalization ability, and endosomal escape capacity. Finally, we evaluated their miRNA transfection capability and efficacy in Neuro-2a cells and rat primary hippocampal neurons. The results indicate that EPA and its copolymers, incorporating ß-cyclodextrins with or without polyethylene glycol acrylate derivatives, can be promising vehicles for miRNA administration to neural cells when all experiments on Neuro-2a cells and primary hippocampal neurons are considered together.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Pharmaceutics Año: 2023 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Pharmaceutics Año: 2023 Tipo del documento: Article País de afiliación: España